Ticho Barry
Transaction: 08/03/2026
SELL
Change
-1,269
Price
$29.45
Filing
08/05/2026
Type
SELL
Stoke Therapeutics, Inc.
STOK • Biotechnology
$29.81
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.97B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 113.7%Positive free cash flow · 0.76Manageable debt level · 0Healthy liquidity · 5.28Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:38 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$29.81
Change0.00%
Shares Out66.02M
Market Cap$1.97B
Enterprise Value$1.68B
52W Range15.50 - 40.22
Beta1.23
P/E-9.47
P/S71.34
P/B5.70
P/FCF-10.89
EV/Sales60.72
Price$29.81
Change0.00%
Shares Out66.02M
Market Cap$1.97B
Enterprise Value$1.68B
52W Range15.50 - 40.22
Beta1.23
P/E-9.47
P/S71.34
P/B5.70
P/FCF-10.89
EV/Sales60.72
EV/EBITDA-7.73
EV/FCF-9.27
Earnings Yield-10.56%
FCF Yield-9.18%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-11.16%
Profit Margin-3.73%
Debt/Eq0.00
Current Ratio5.28
Quick Ratio5.28
Target$51.00
Target Upside71.08%
Target Median$51.00
Target Range44.00 - 58.00
Volume977.97K
Avg Volume719.47K
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
35/100
Why this score▼
Positive revenue growth · 113.7%Positive free cash flow · 0.76Manageable debt level · 0Healthy liquidity · 5.28Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 16 analyst votes · 2026-09-05
91/100
Bullish
Bullish
13
Hold
3
Bearish
0
Price Target
2026-08-13
Low
$40.00
Mean
$47.33
Median
$44.00
High
$58.00
Insider Transactions
Recent executive and insider activity
Harrison Seth Loring
Transaction: 07/16/2026
SELL
Change
-29,747
Price
$10.90
Filing
07/17/2026
Type
SELL
McCauley Thomas
Transaction: 07/15/2026
BUY
Change
+225,000
Price
$29.91
Filing
07/17/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Ticho Barry | SELL | -1,269 | $29.45 | 08/03/2026 | 08/05/2026 |
| Harrison Seth Loring | SELL | -29,747 | $10.90 | 07/16/2026 | 07/17/2026 |
| McCauley Thomas | BUY | +225,000 | $29.91 | 07/15/2026 | 07/17/2026 |
| McCauley Thomas | OTHER | 0 | Not reported | 07/13/2026 | 07/17/2026 |
| Ticho Barry | SELL | -500 | $33.27 | 07/01/2026 | 07/06/2026 |
| Allan Jonathan | SELL | -1,457 | $29.95 | 06/16/2026 | 06/18/2026 |
| Burstein Jennifer | BUY | +17,786 | $29.46 | 06/03/2026 | 06/05/2026 |
| Harrison Seth Loring | BUY | +17,786 | $29.46 | 06/03/2026 | 06/05/2026 |
| Kaye Edward M. MD | BUY | +17,786 | $29.46 | 06/03/2026 | 06/05/2026 |
| Krainer Adrian R. | BUY | +17,786 | $29.46 | 06/03/2026 | 06/05/2026 |
| LEVIN ARTHUR A | BUY | +17,786 | $29.46 | 06/03/2026 | 06/05/2026 |
| Smith Julie | BUY | +17,786 | $29.46 | 06/03/2026 | 06/05/2026 |
| TZIANABOS ARTHUR | BUY | +17,786 | $29.46 | 06/03/2026 | 06/05/2026 |
| Ticho Barry | SELL | -1,795 | $30.58 | 06/01/2026 | 06/03/2026 |
| Ticho Barry | SELL | -2,243 | $32.79 | 05/01/2026 | 05/05/2026 |
| Kahn Clare | OTHER | 0 | Not reported | 04/03/2026 | 04/07/2026 |
| Kahn Clare | BUY | +30,782 | $32.79 | 04/03/2026 | 04/07/2026 |
| Ticho Barry | SELL | -1,838 | $32.66 | 04/01/2026 | 04/03/2026 |
| Allan Jonathan | SELL | -601 | $34.41 | 03/20/2026 | 03/24/2026 |
| Ticho Barry | SELL | -1,461 | $29.99 | 03/19/2026 | 03/19/2026 |